Vergleich

CREBBP Peptide - N-terminal region (AAP43609)

ArtNr AAP43609
Hersteller AVIVA Systems Biology
Menge 100 ug
Kategorie
Typ Peptides
Format Lyophilized powder
Applikationen WB, IHC
Specific against other
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias CBP, KAT3A, RSTS, RTS
Similar products CREBBP
Lieferbar
Description
This is a synthetic peptide designed for use in combination with anti-CREBBP antibody (Catalog #: ARP43609_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Gene symbol
CREBBP
Protein size
2404
Molecular weight
261kDa
Product format
Lyophilized powder
Gene id
1387
Reconstitution and storage
Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS. For longer periods of storage, store at -20C. Avoid repeat freeze-thaw cycles.
Partner proteins
EGR1, AIRE, BNIP3L, BRCA1, CCND1, CDKN1A, CDKN1A, CREB1, CREB1, CTBP1, DAXX, EGR1, H3F3A, HCVgp1, HNF1A, HNF4A, HSF1, HTT, HTT, ICAM1, IRF3, MAF, NAP1L1, NCOA3, NCOA3, NCOA3, PAX5, RELA, RELA, SMAD2, SMAD2, SMAD3, STAT1, STAT1, STAT3, TACC2, TCF12, TCF12, TFF1, TNFSF10, TP53, ACTA2, ACVR1, AIRE, ALX1, AP1B1, AR, ATF1, BCL3, BRCA1, CALCOCO1, CAMK4, CARM1, CDC25B, CDH2, CDK5RAP3, CDX2, CEBPA, CEBPB, CEBPD, CENPJ, CHUK, CITED1, CITED2, CNOT3, CREB1, CREBBP, CREM, CRX, CSK, CSNK2A1, CSNK2A2, CTBP1, CTNNB1, CUX1, DACH1, DAXX, DDX5, E2F1, E2F5, EBF1, EGR1, EID3, EIF2B1, ELF3, ELK1, EP300, ESR1, ETS1, ETS2, EWSR1, FGFR1, FHL2, FOXM1, FOXO1, FOXO4, GABPA, GAK, GATA1, GCM1, GLI3, GMEB1, GMEB2, GTF2B, H3F3B, HDAC1, HDAC3, HIF1A, HIPK2, HLF, HMGA1, HNF1A, HNF1B, HNF4A, HOXA10, HOXA11, HOXA9, HOXB1, HOXB2, HOXB3, HOXB4, HOXB6, HOXB7, HOXB9, HOXD10, HOXD4, HSF1, HTT, IKBKG, IRF3, IRF7, JDP2, JUN, KAT2A, KAT2B, KAT5, KHDRBS1, KLF13, KLF4, KLF5, KPNA2, MAF, MAFG, MAML1, MAML2, MBD2, MDC1, MDM2, MECOM, MGMT, MLL, MSH2, MSH6, MSX1, MYB, MYBL1, MYBL2, MYC, MYOD1, N4BP2, NAP1L1, NCOA1, NCOA2, NCOA3, NCOA6, NEUROG1, NFATC2, NFATC4, NFE2, NFE2L2, NFIA, NFIC, NKX2-1, NLK, NPAS2, NPAT, NR3C1, NUP98, ONECUT1, PAX5, PCMT1, PELP1, PHOX2A, PIAS1, PML, POLR2A, POU1F1, POU2F3, PRKCD, PROX1, PTMA, RBBP4, RBCK1, RELA, RPS6KA1, RPS6KA3, RPS6KA5, RXRG, SERTAD1, SERTAD2, SERTAD3, SH3GL1, SMAD2, SMAD3, SMAD4, SND1, SNIP1, SOX9, SPI1, SPIB, SRCAP, SREBF1, SREBF2, SRF, SS18L1, STAT1, STAT2, STAT3, STAT4, STAT6, SUV39H1, TACC2, TCF12, TCF3, TDG, TGS1, THRA, TP53, TP73, TRERF1, TRIP10, TRIP4, UBTF, VDR, WT1, YWHAH, ZBTB17, ZBTB2, ZNF639, ABCA1, AIRE, AR, ATF1, ATF2, ATF4, BRCA1, CCNC, CDK8, CITED1, CITED2, CREB1, CSK, CSNK2A1, CSNK2A2, CTNNB1, CUX1, DDX5, E2F1, E2F3, EBF1, EGR1, EP300, ESR1, EWSR1, FOS, FOXO1, FOXO4, GATA1, GLI3, GTF2B, HIF1A, HIPK2, HIST3H3, HIST4H4, HNF1A, HNF4A, HOXB7, HTT, ING1, IRF3, JUN, KAT2B, KHDRBS1, KLF1, KLF13, KLF4, KLF5, MAF, MAML1, MECOM, MED21, MGMT, MLL, MSX1, MYB, MYBL2, MYOD1, N4BP2, NCOA1, NCOA3, NCOA6, NEUROG1, NFATC2, NFATC4, NFE2, NFE2L2, NKX2-1, NPAS2, NR3C1, NUP98, ONECUT1, PELP1, PHOX2A, PIAS3, PML, POLR2A, PPARG, PPARGC1A, PTMA, RBBP4, RBBP7, RELA, RPA2, RPS6KA2, RPS6KA3, SERTAD1, SMAD1, SMARCA4, SMARCB1, SNIP1, SREBF1, SREBF2, SRF, SS18L1, STAT1, STAT2, STAT3, STAT6, TCF3, TDG, TGS1, TP53, TRERF1, TRIP4, XRCC6
Description of target
CREBBP is involved in the transcriptional coactivation of many different transcription factors. First isolated as a nuclear protein that binds to cAMP-response element binding protein (CREB), this gene is now known to play critical roles in embryonic development, growth control, and homeostasis by coupling chromatin remodeling to transcription factor recognition. CREBBP has intrinsic histone acetyltransferase activity and also acts as a scaffold to stabilize additional protein interactions with the transcription complex. This protein acetylates both histone and non-histone proteins. This protein shares regions of very high sequence similarity with protein p300 in its bromodomain, cysteine-histidine-rich regions, and histone acetyltransferase domain.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 100 ug
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen